Stock Information
Vericel Corp (VCEL)
Ticker Symbol: VCEL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,804.48 mil
Piotroski score: 7
PE Ratio: 106.9785
EPS (TTM): 0.2633
Revenue (TTM): $4.78 M
Dividend Yield: N/A%
ROE: 5.17%
Latest News
-
Vericel Corporation 2025 Q4 - Results - Earnings Call Presentation
Fri, Feb 27, 2026 8:01 PM
-
HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $64
Fri, Feb 27, 2026 12:11 PM
-
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case
Fri, Feb 27, 2026 11:12 AM
-
Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability
Thu, Feb 26, 2026 2:42 PM
-
Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript
Thu, Feb 26, 2026 12:58 PM
-
Vericel Sees FY2026 Sales $316.000M-$326.000M vs $325.310M Est
Thu, Feb 26, 2026 9:04 AM
-
Vericel Q4 EPS $0.45 Beats $0.39 Estimate, Sales $92.918M Beat $91.122M Estimate
Thu, Feb 26, 2026 9:04 AM
-
Earnings Breakdown: Vericel Q4
Thu, Feb 26, 2026 9:04 AM
-
Earnings Scheduled For February 26, 2026
Thu, Feb 26, 2026 7:11 AM
Key Financials
Financial data not available
